AnalyzeDirect

Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin

Iwan E. Bennett1, Kathryn M. Field3, Christopher M. Hovens1, Bradford A. Moffat2, Mark A. Rosenthal3, Katharine Drummond1,4, Andrew H. Kaye1,4, Andrew P. Morokoff1,4. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin Journal of Neuro-Oncology. November 28 2016. Publication Date November 2016 How Analyze was Used “Using Analyze…